← Back to Search

Behavioural Intervention

TFP for Borderline Personality Disorder

N/A
Waitlist Available
Led By John F Clarkin, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 3 months for 18-month duration of treatment
Awards & highlights

Study Summary

This trial is examining the effects of 18-month psychotherapy treatment for borderline personality disorder. Patients will be assessed before and after treatment, and compensated for their time.

Eligible Conditions
  • Borderline Personality Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 3 months for 18-month duration of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 3 months for 18-month duration of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Symptom Inventory (BSI; Derogatis, 1993)
Overt Aggression Scale (OAS-M; Coccaro et al., 1991)
Social Adjustment Scale (SAS; Weissman, 1971)
Secondary outcome measures
Affective Lability Scale (ALS; Harvey et al., 1989)
Reflective Function Questionnaire (RFQ; Fonagy & Luyten, 2009)
State-Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transference-focused Psychotherapy (TFP)Experimental Treatment1 Intervention
Transference-focused psychotherapy is a psychodynamic talk therapy utilized in treating borderline personality disorder in men and women.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,234 Total Patients Enrolled
John F Clarkin, PhDPrincipal InvestigatorWeill Medical College of Cornell University
Francis S Lee, M.D., PhDPrincipal InvestigatorWeill Medical College of Cornell University

Media Library

18-Month Psychotherapy of Borderline Personality Disorder (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03329677 — N/A
Borderline Personality Disorder Research Study Groups: Transference-focused Psychotherapy (TFP)
Borderline Personality Disorder Clinical Trial 2023: 18-Month Psychotherapy of Borderline Personality Disorder Highlights & Side Effects. Trial Name: NCT03329677 — N/A
18-Month Psychotherapy of Borderline Personality Disorder (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03329677 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity for enrollment in this trial?

"According to clinicaltrials.gov, this trial has ceased recruitment. Initially posted on January 1st 2016 and last updated December 21st 2021, the study is not actively seeking participants at present; however there are 60 other trials presently recruiting patients."

Answered by AI

Is the age range for participants of this research study limited to under 45?

"This study requires participants to be within the ages of 18 and 35. In addition, there are 6 studies specifically for persons under 18 years old and 32 trials designed for those over 65 years in age."

Answered by AI

Could I potentially become a volunteer for this medical experiment?

"This trial is looking to accept 59 participants with a diagnosis of borderline personality disorder, aged 18-35 years old."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Illinois
New York
How old are they?
18 - 65
What site did they apply to?
Personality Disorders Institute of the Weill Medical College of Cornell University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
~7 spots leftby Apr 2025